Cochrane Abstracts
Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lipid-lowering Agents for Nephrotic Syndrome: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid_lowering_agents_for_nephrotic_syndrome:_Cochrane_systematic_review.
Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid_lowering_agents_for_nephrotic_syndrome:_Cochrane_systematic_review. Accessed April 22, 2025.
Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid_lowering_agents_for_nephrotic_syndrome:_Cochrane_systematic_review
Lipid-lowering Agents for Nephrotic Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid_lowering_agents_for_nephrotic_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review
ID - 437563
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437563/all/Lipid_lowering_agents_for_nephrotic_syndrome:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
